Close

Bionano Genomics Announces Financial Results for the Three and Twelve Months Ended December 31, 2020 and Highlights Recent Corporate Updates

Go back to Bionano Genomics Announces Financial Results for the Three and Twelve Months Ended December 31, 2020 and Highlights Recent Corporate Updates

BioNano Genomics, Inc. (BNGO) Reports Q4 Revenue of $4M

March 23, 2021 4:08 PM EDT

BioNano Genomics, Inc. (NASDAQ: BNGO) reported Q4 revenue of $4 million versus the consensus estimate of $3.5 million.

2020 was an important momentum-building year for Bionano and one that allowed us to showcase many of our strengths. Despite 2020s challenges, we executed well on our commercial offerings for Saphyr® by expanding the number of systems in the field and the number of samples analyzed in our data services lab. We believe this... More